When was LEADOPTIK founded?

LEADOPTIK was founded in 2020 and raised its 1st funding round within a year of its incorporation.

Where is LEADOPTIK located?

LEADOPTIK is headquartered in Milpitas, United States.

Who is the current CEO of LEADOPTIK?

Reza Khorasaninejad of LEADOPTIK. They have also founded 1 company.

How many employees does LEADOPTIK have?

As of Sep 30, 2026, the latest employee count at LEADOPTIK is 16.

Is LEADOPTIK a funded company?

LEADOPTIK is a funded company, having raised a total of $11.2M across 3 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on 2020.

When was the latest funding round of LEADOPTIK?

LEADOPTIK's latest funding was a $***** Seed round on Aug 19, 2025, with participation from 0 investor. Its primary sector is Oncology. In United States, the Oncology sector has seen $6.51B in funding in 2026 to date.

Where does LEADOPTIK rank among its competitors?

LEADOPTIK ranks 2nd amongst 29 active competitors, of which 12 are funded. It stands 4th in terms of total funding among its competitors. The most recent competitor to raise funding was Selio Medical, which secured $5.81M in Aug, 2026.

Who are the top competitors of LEADOPTIK?

LEADOPTIK's top competitors include Body Vision Medical, Reveal Dx and Selio Medical. Among them, Selio Medical secured the most recent funding round in August, 2026.

LEADOPTIK - 2026 Company Profile, Team, Funding & Competitors

Company Details

Provider of AI-powered optical processors. It develops an optical technology that uses machine learning for image analysis applications.

Website: www.leadoptik.com/
Social

Key Metrics

Founded Year

2020

Location

Milpitas, United States

Stage

Seed

Total Funding

$11.2M in 3 rounds

Latest Funding Round

Seed, Aug 19, 2025, $*****

Investors

HAX & 9 more

Ranked

2^nd among 29 active competitors

Employee Count

16 as on Sep 30, 2026

Similar Companies

Body Vision Medical & 38 more

View LEADOPTIK's full profile

LEADOPTIK is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Leadoptik Inc. CIN: 853781770 , United States, Active	Dec 31, 2019	-	-	-

LEADOPTIK has raised a total funding of $11.2M over 3 rounds. Its first funding round was on 2020. LEADOPTIK has 8 institutional investors and 2 angel investors.

Here is the list of recent funding rounds of LEADOPTIK:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Aug 19, 2025	2452617	Seed	3114973	1681171	5344755	8830735
May 22, 2023	3029494	Seed	6696017	6077640	9645862	SOSV & 6 more
2020	4886	Seed	6257	2193	HAX	4904

Access funding benchmarks and valuations. Sign up today!

View details of LEADOPTIK's funding rounds and investors

The founders of LEADOPTIK is Reza Khorasaninejad. Reza Khorasaninejad is the CEO of LEADOPTIK.

Here are the details of LEADOPTIK's key team members:

Reza Khorasaninejad: Co-Founder & CEO of LEADOPTIK and founder of 1 other company.
Contact Info: 1 email address

View details of LEADOPTIK's Founder profiles and Board Members

LEADOPTIK's employee count trend

LEADOPTIK has 16 employees as of Sep 26. Here is LEADOPTIK's employee count trend over the years:

Uncover LEADOPTIK's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of LEADOPTIK include Body Vision Medical, Reveal Dx and Selio Medical. Here is the list of Top 10 competitors of LEADOPTIK, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Body Vision Medical 2014, Waltham (United States), Series C	Developer of AI-driven imaging system for lung cancer diagnostic intervention	$34.5M	Business Asia Consulting, SPRIM Global Investments ... & 10 others	58/100
2nd	LEADOPTIK 2020, Milpitas (United States), Seed	Provider of AI-powered optical processors	$11.2M	Applied Materials, TSVC & 8 others	58/100
3rd	Reveal Dx 2021, Seattle (United States), Series B	AI-based lung diagnosis tool for healthcare professionals	$12.3M	4DMedical, Westway Capital & 1 others	53/100
4th	Selio Medical 2016, Dublin (Ireland), Series A	Developer of device to prevent pneumothorax during transthoracic needle biopsy	$5.81M	EIC Fund, MedTech Innovator & 2 others	52/100
5th	VOCxI Health 2022, Arden Hills (United States), Seed	Developer of sensor-based breath diagnostic platforms	$8.16M	Engage, Minnesota.gov & 3 others	51/100
6th	Veran Medical 2005, St. Louis (United States), Acquired	Provider of diagnosis of lung cancer by soft tissue navigation	$155M	Prolog Ventures, Versant Ventures & 13 others	51/100
7th	Imbio 2005, Minneapolis (United States), Acquired	AI-powered medical imaging analysis for personalized lung and cardiothoracic care	$2.58M	HHS, Invenshure	40/100
8th	ArtiQ 2019, Leuven (Belgium), Acquired	AI-powered software to optimize clinical trials and enhance diagnostic processes	$1.12M	KU Leuven, KBC Focus Fund & 2 others	40/100
9th	Prana Thoracic 2022, Houston (United States), Series A	Developer of minimally invasive lung tissue excision tool for lung cancer	$7.5M	New World Angels, cultivate(MD) & 7 others	39/100
10th	Sime Dx 2010, London (United Kingdom), Seed	Point-of-care digital digital diagnostics	$971K	Tricor Group, Pique & 12 others	39/100